Selenium partially prevents cisplatin-induced neurotoxicity: A preliminary study

NeuroToxicology

Volumn 42, Issue , 2014, Pages 71-75

  Erken, Haydar Ali ^a   Koç, Emine Rabia ^a   Yazici, Haşmet ^a   Yay, Arzu ^b   Önder, Gözde Özge ^b   Sarici, Saim Furkan ^c  

^a BALIKESIR UNIVERSITY   (Turkey)

^b ERCIYES UNIVERSITY   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Cisplatin; Neuropathy; Neuroprotective effect; Neurotoxicity; Selenium

Indexed keywords

CISPLATIN; SELENIUM; SODIUM CHLORIDE; ANTINEOPLASTIC AGENT; NEUROPROTECTIVE AGENT; TRACE ELEMENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; HISTOPATHOLOGY; MALE; NERVE CONDUCTION; NERVE FIBER MEMBRANE POTENTIAL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; RAT; ACTION POTENTIAL; ANIMAL; ANTAGONISTS AND INHIBITORS; CYTOLOGY; DRUG EFFECTS; NERVE DEGENERATION; NERVE FIBER; PHYSIOLOGY; PILOT STUDY; SCIATIC NERVE;

ACTION POTENTIALS; ANIMALS; ANTINEOPLASTIC AGENTS; AXONS; CISPLATIN; MALE; NERVE DEGENERATION; NEURAL CONDUCTION; NEUROPROTECTIVE AGENTS; PILOT PROJECTS; RATS; SCIATIC NERVE; SELENIUM; TRACE ELEMENTS;

EID: 84899848206     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2014.04.002     Document Type: Article

References (69)

1. Ahmad A., Khan M.M., Ishrat T., Khan M.B., Khuwaja G., Raza S.S., et al. Synergistic effect of selenium and melatonin on neuroprotection in cerebral ischemia in rats. Biol Trace Elem Res 2011, 139(1):81-96.
2. Ajith T.A., Abhishek G., Roshny D., Sudheesh N.P. Co-supplementation of single and multi doses of vitamins C and E ameliorates cisplatin-induced acute renal failure in mice. Exp Toxicol Pathol 2009, 61(6):565-571.
3. Amptoulach S., Tsavaris N. Neurotoxicity caused by the treatment with platinum analogues. Chemother Res Pract 2011, 843019:1-5.
4. Argyriou A.A., Chroni E., Koutras A., Iconomou G., Papapetropoulos S., Polychronopoulos P., et al. A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results. Support Care Cancer 2006, 14(11):1134-1140.
5. Ayaz M., Kaptan H. Effects of selenium on electrophysiological changes associated with diabetic peripheral neuropathy. Neural Regen Res 2011, 6:617-622.
6. Ben Amara I., Fetoui H., Guermazi F., Zeghal N. Dietary selenium addition improves cerebrum and cerebellum impairments induced by methimazole in suckling rats. Int J Dev Neurosci 2009, 27(7):719-726.
7. Ben Amara I., Karray A., Hakim A., Ben Ali Y., Troudi A., Soudani N., et al. Dimethoate induces kidney dysfunction, disrupts membrane-bound ATPases and confers cytotoxicity through DNA damage. Protective effects of vitamin e and selenium. Biol Trace Elem Res 2013, 156(1-3):230-242.
8. Bilginoglu A., Seymen A., Tuncay E., Zeydanli E., Aydemir-Koksoy A., Turan B. Antioxidants but not doxycycline treatments restore depressed beta-adrenergic responses of the heart in diabetic rats. Cardiovasc Toxicol 2009, 9(1):21-29.
9. Brouwers E.E., Huitema A.D., Boogerd W., Beijnen J.H., Schellens J.H. Persistent neuropathy after treatment with cisplatin and oxaliplatin. Acta Oncol 2009, 48:832-841.
10. Cao J.J., Gregoire B.R., Zeng H. Selenium deficiency decreases antioxidative capacity and is detrimental to bone microarchitecture in mice. J Nutr 2012, 142(8):1526-1531.
11. Carozzi V., Chiorazzi A., Canta A., Oggioni N., Gilardini A., Rodriguez-Menendez V., et al. Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity. Eur J Cancer 2009, 45(4):656-665.
12. Carozzi V.A., Marmiroli P., Cavaletti G. The role of oxidative stress and anti-oxidant treatment in platinum-induced peripheral neurotoxicity. Curr Cancer Drug Targets 2010, 10(7):670-682.
13. Cavaletti G., Minoia C., Schieppati M., Tredici G. Protective effects of glutathione on cisplatin neurotoxicity in rats. Int J Radiat Oncol Biol Phys 1994, 29(4):771-776.
14. Cepeda V., Fuertes M.A., Castilla J., Alonso C., Quevedo C., Perez J.M. Biochemical mechanisms of cisplatin cytotoxicity. Anticancer Agents Med Chem 2007, 7:3-18.
15. Chen J., Berry M.J. Selenium and selenoproteins in the brain and brain diseases. J Neurochem 2003, 86(1):1-12.
16. Di Scipio F., Raimondo S., Tos P., Geuna S. A simple protocol for paraffin-embedded myelin sheath staining with osmium tetroxide for light microscope observation. Microsc Res Tech 2008, 71(7):497-502.
17. Englander E.W. DNA damage response in peripheral nervous system: coping with cancer therapy-induced DNA lesions. DNA Repair (Amst) 2013, 12(8):685-690.
18. Erdem T., Bayindir T., Filiz A., Iraz M., Selimoglu E. The effect of resveratrol on the prevention of cisplatin ototoxicity. Eur Arch Otorhinolaryngol 2012, 269(10):2185-2188.
19. Erken H.A., Erken G., Colak R., Genç O. Exercise and DHA prevent the negative effects of hypoxia on EEG and nerve conduction velocity. High Alt Med Biol 2013, 14(4):360-366.
20. Gabaizadeh R., Staecker H., Liu W., Van De Water T.R. BDNF protection of auditory neurons from cisplatin involves changes in intracellular levels of both reactive oxygen species and glutathione. Brain Res Mol Brain Res 1997, 50(1-2):71-78.
21. Gill J.S., Windebank A.J. Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle. J Clin Invest 1998, 101(12):2842-2850.
22. Godoi G.L., de Oliveira Porciúncula L., Schulz J.F., Kaufmann F.N., da Rocha J.B., de Souza D.O., et al. Selenium compounds prevent amyloid β-peptide neurotoxicity in rat primary hippocampal neurons. Neurochem Res 2013, 38(11):2359-2363.
23. Gupta R., Kazmi I., Afzal M., Khan R., Chauhan M., Al-Abbasi F.A., et al. Combination of sulfamethoxazole and selenium in anticancer therapy: a novel approach. Mol Cell Biochem 2013, 384(1-2):279-285.
24. Hamers F.P., Brakkee J.H., Cavalletti E., Tedeschi M., Marmonti L., Pezzoni G., et al. Reduced glutathione protects against cisplatin-induced neurotoxicity in rats. Cancer Res 1993, 53(3):544-549.
25. Hawkes W.C., Richter D., Alkan Z. Dietary selenium supplementation and whole blood gene expression in healthy North American men. Biol Trace Elem Res 2013, 155(2):201-208.
26. Huang T., Cheng A.G., Stupak H., Liu W., Kim A., Staecker H., et al. Oxidative stress-induced apoptosis of cochlear sensory cells: otoprotective strategies. Int J Dev Neurosci 2000, 18(2-3):259-270.
27. Ishrat T., Parveen K., Khan M.M., Khuwaja G., Khan M.B., Yousuf S., et al. Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type. Brain Res 2009, 1281:117-127.
28. Jaggi A.S., Singh N. Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy. Toxicology 2012, 291(1-3):1-9.
29. Kamisli S., Ciftci O., Kaya K., Cetin A., Kamisli O., Ozcan C. Hesperidin protects brain and sciatic nerve tissues against cisplatin-induced oxidative, histological and electromyographical side effects in rats. Toxicol Ind Health 2013, 10.1177/0748233713483192.
30. Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 2007, 7:573-584.
31. Krarup-Hansen A., Rietz B., Krarup C., Heydorn K., Rorth M., Schmalbruch H. Histology and platinum content of sensory ganglia and sural nerves in patients treated with cisplatin and carboplatin: an autopsy study. Neuropathol Appl Neurobiol 1999, 25(1):29-40.
32. Krarup-Hansen A., Helweg-Larsen S., Schmalbruch H., Rørth M., Krarup C. Neuronal involvement in cisplatin neuropathy: prospective clinical and neurophysiological studies. Brain 2007, 130:1076-1088.
33. Leal-Cardoso J.H., Moreira M.R., da Cruz G.M., de Morais S.M., Lahlou M.S., Coelho-de-Souza A.N. Effects of essential oil of Alpinia zerumbet on the compound action potential of the rat sciatic nerve. Phytomedicine 2004, 11:549-553.
34. Li G., Liu W., Frenz D. Cisplatin ototoxicity to the rat inner ear: a role for HMG1 and iNOS. Neurotoxicology 2006, 27(1):22-30.
35. Li W.H., Shi Y.C., Tseng I.L., Liao V.H. Protective efficacy of selenite against lead-induced neurotoxicity in Caenorhabditis elegans. PLoS ONE 2013, 8(4). 10.1371/journal.pone.0062387.
36. Maraldi T., Riccio M., Zambonin L., Vinceti M., De Pol A., Hakim G. Low levels of selenium compounds are selectively toxic for a human neuron cell line through ROS/RNS increase and apoptotic process activation. Neurotoxicology 2011, 32(2):180-187.
37. Melli G., Taiana M., Camozzi F., Triolo D., Podini P., Quattrini A., et al. Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy. Exp Neurol 2008, 214(2):276-284.
38. Mendonça L.M., da Silva Machado C., Teixeira C.C., de Freitas L.A., Bianchi Mde L., Antunes L.M. Curcumin reduces cisplatin-induced neurotoxicity in NGF-differentiated PC12 cells. Neurotoxicology 2013, 34:205-211.
39. Miller S., Walker S.W., Arthur J.R., Nicol F., Pickard K., Lewin M.H., et al. Selenite protects human endothelial cells from oxidative damage and induces thioredoxin reductase. Clin Sci (Lond) 2001, 100(5):543-550.
40. Miyama T., Minowa K., Seki H., Tamura Y., Mizoguchi I., Ohi G., et al. Chronological relationship between neurological signs and electrophysiological changes in rats with methylmercury poisoning - special reference to selenium protection. Arch Toxicol 1983, 52:173-181.
41. Mong P.Y., Petrulio C., Kaufman H.L., Wang Q. Activation of Rho kinase by TNF-alpha is required for JNK activation in human pulmonary microvascular endothelial cells. J Immunol 2008, 180:550-558.
42. Moreira M.R., Cruz G.M., Lopes M.S., Albuquerque A.A., Leal-Cardoso J.H. Effects of terpineol on the compound action potential of the rat sciatic nerve. Braz J Med Biol Res 2001, 34:1337-1340.
43. Naziroglu M., Karaoǧlu A., Aksoy A.O. Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. Toxicology 2004, 195(2-3):221-230.
44. Ognjanović B.I., Djordjević N.Z., Matić M.M., Obradović J.M., Mladenović J.M., Stajn AŠ, et al. Lipid peroxidative damage on cisplatin exposure and alterations in antioxidant defense system in rat kidneys: a possible protective effect of selenium. Int J Mol Sci 2012, 13(2):1790-1803.
45. Orhan B., Yalcin S., Nurlu G., Zeybek D., Muftuoglu S. Erythropoietin against cisplatin-induced peripheral neurotoxicity in rats. Med Oncol 2004, 21(2):197-203.
46. Ozols R.F., Young R.C. High-dose cisplatin therapy in ovarian cancer. Semin Oncol 1985, 12(4 (Suppl. 6)):21-30.
47. Pace A., Savarese A., Picardo M., Maresca V., Pacetti U., Del Monte G., et al. Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. J Clin Oncol 2003, 21(5):927-931.
48. Pace A., Giannarelli D., Galie' E., Savarese A., Carpano S., Della Giulia M., Vitamin E., et al. neuroprotection for cisplatin neuropathy: a randomized, placebo-controlled trial. Neurology 2010, 74(9):762-766.
49. Paksoy M., Ayduran E., Sanli A., Eken M., Aydin S., Oktay Z.A. The protective effects of intratympanic dexamethasone and vitamin E on cisplatin-induced ototoxicity are demonstrated in rats. Med Oncol 2011, 28(2):615-621.
50. Peters U., Preisler-Adams S., Hebeisen A., Hahn M., Seifert E., Lanvers C., et al. Glutathione S-transferase genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin. Anticancer Drugs 2000, 11(8):639-643.
51. Pinton S., Bruning C.A., Sartori Oliveira C.E., Prigol M., Nogueira C.W. Therapeutic effect of organoselenium dietary supplementation in a sporadic dementia of Alzheimer's type model in rats. J Nutr Biochem 2013, 24(1):311-317.
52. Podratz J.L., Knight A.M., Ta L.E., Staff N.P., Gass J.M., Genelin K., et al. Cisplatin induced mitochondrial DNA damage in dorsal root ganglion neurons. Neurobiol Dis 2011, 41(3):661-668.
53. Rezvanfar M.A., Rezvanfar M.A., Shahverdi A.R., Ahmadi A., Baeeri M., Mohammadirad A., et al. Protection of cisplatin-induced spermatotoxicity, DNA damage and chromatin abnormality by selenium nano-particles. Toxicol Appl Pharmacol 2013, 266(3):356-365.
54. Roelofs R.I., Hrushesky W., Rogin J., Rosenberg L. Peripheral sensory neuropathy and cisplatin chemotherapy. Neurology 1984, 34(7):934-938.
55. Siegal T., Haim N. Cisplatin-induced peripheral neuropathy. Frequent off-therapy deterioration, demyelinating syndromes, and muscle cramps. Cancer 1990, 66:1117-1123.
56. Screnci D., McKeage M.J. Platinum neurotoxicity: clinical profiles, experimental models and neuroprotective approaches. J Inorg Biochem 1999, 77(1-2):105-110.
57. Shabani M., Nazeri M., Parsania S., Razavinasab M., Zangiabadi N., Esmaeilpour K., et al. Walnut consumption protects rats against cisplatin-induced neurotoxicity. Neurotoxicology 2012, 33(5):1314-1321.
58. Shokrzadeh M., Ahangar N., Abdollahi M., Shadboorestan A., Omidi M., Payam S.S. Potential chemoprotective effects of selenium on diazinon-induced DNA damage in rat peripheral blood lymphocyte. Hum Exp Toxicol 2013, 32(7):759-765.
59. Sweeney C.J., Zhu J., Sandler A.B., Schiller J., Belani C.P., Langer C., et al. Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a phase II trial in patients with metastatic nonsmall cell lung carcinoma. Cancer 2001, 92(10):2639-2647.
60. Ta L.E., Espeset L., Podratz J., Windebank A.J. Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding. Neurotoxicology 2006, 27(6):992-1002.
61. Tuncer S., Dalkilic N., Akif Dunbar M., Keles B. Comparative effects of α lipoic acid and melatonin on cisplatin-induced neurotoxicity. Int J Neurosci 2010, 120(10):655-663.
62. Turan M., Cayir A., Cetin N., Suleyman H., Turan I.S., Tan H. An investigation of the effect of thiamine pyrophosphate on cisplatin-induced oxidative stress and DNA damage in rat brain tissue compared with thiamine: thiamine and thiamine pyrophosphate effects on cisplatin neurotoxicity. Hum Exp Toxicol 2014, 33(1):14-21.
63. Türker Y., Naziroǧlu M., Gümral N., Celik O., Saygin M., Cömlekçi S., et al. Selenium and l-carnitine reduce oxidative stress in the heart of rat induced by 2.45-GHz radiation from wireless devices. Biol Trace Elem Res 2011, 143(3):1640-1650.
64. Uǧuz A.C., Naziroǧlu M. Effects of selenium on calcium signaling and apoptosis in rat dorsal root ganglion neurons induced by oxidative stress. Neurochem Res 2012, 37(8):1631-1638.
65. Valentovic M.A., Ball J.G., Mike Brown J., Terneus M.V., McQuade E., Van Meter S., et al. Resveratrol attenuates cisplatin renal cortical cytotoxicity by modifying oxidative stress. Toxicol In Vitro 2014, 28(2):248-257.
66. Ward J.D., Barnes C.G., Fisher D.J., Jessop J.D. Improvement in nerve conduction following treatment in newly diagnosed diabetics. Lancet 1971, 1(7696):428-430.
67. Weeks B.S., Hanna M.S., Cooperstein D. Dietary selenium and selenoprotein function. Med Sci Monit 2012, 18(8). RA127-32.
68. Weijl N.I., Hopman G.D., Wipkink-Bakker A., Lentjes E.G., Berger H.M., Cleton F.J., et al. Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients. Ann Oncol 1998, 9(12):1331-1337.
69. Yang L., Bashaw G.J. Son of sevenless directly links the robo receptor to rac activation to control axon repulsion at the midline. Neuron 2006, 52:595-607.